Organon & Co. (OGN)
(Delayed Data from NYSE)
$19.49 USD
-0.69 (-3.42%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $19.50 +0.01 (0.05%) 6:12 PM ET
3-Hold of 5 3
A Value F Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 35% (162 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.86 | 2.02 | 9.99 |
Current Quarter Estimate | 0.97 | 5.18 | 61.00 |
Year Ago Quarter Estimate | 0.87 | 1.42 | 54.84 |
Next Quarter Estimate | 0.99 | 4.75 | 63.00 |
Next Year Estimate | 4.45 | 26.08 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.59 | 7.40 | 15.67 |
Next Year | 2.77 | 18.60 | 11.34 |
Last 5 Years | NA | 9.60 | 8.10 |
Next 5 Years | 5.50 | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 4.93 | -3.10 |
Price/Book (MRQ) | 36.08 | 2.05 |
Price/Cash Flow (MRFY) | 4.02 | 13.48 |
Dividend Yield | 5.55% | 0.00% |
Net Profit Margin (TTM) | 15.76% | -11.31% |
Return on Equity (TTM) | -840.29% | -10.25% |
Debt to Equity (MRQ) | 60.05 | 28.67 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.